ZymoGenetics, Inc. (ZGEN)'s Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
10/26/2009 7:56:50 AM
Xconomy.com -- One of the key people who transformed ZymoGenetics from a basic research institute into a more balanced biotech company with both R and D, has set up shop in a rival startup just a few blocks away on Seattle’s Eastlake Avenue. If he plays his cards right, this little company will surpass his former employer, with what he hopes will be an even better treatment to control bleeding.
comments powered by